News from biotrends research group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 23, 2010, 08:00 ET

TreatmentTrends®: Gout Study Highlights Differences in Clinical Management of Gout Between Primary Care Physicians and Rheumatologists

BioTrends Research Group, Inc. is pleased to announce the recent publication of a syndicated report, TreatmentTrends®: Gout.  This...

Nov 23, 2010, 08:00 ET

BioTrends Report Based on Patient Chart Data Uncovers Current Practices in the Management of Renal Anemia Among Chronic Kidney Disease Patients

BioTrends Research Group, Inc. released ChartTrends®: Renal Anemia in Chronic Kidney Disease Non-Dialysis (CKD-ND), an annual syndicated...

Nov 03, 2010, 09:48 ET

Rheumatoid Arthritis Patient Share of Actemra Projected to Exceed Patient Share of Cimzia and Simponi Among the Medicare Population

Bio-Trends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Rheumatoid Arthritis Q3 2010.  This...

Nov 02, 2010, 09:13 ET

ChartTrends®: Multiple Sclerosis Report Reveals the Latest Approach to the Treatment and Management of MS

BioTrends Research Group, Inc. has released a syndicated report focused on the management and treatment of multiple sclerosis (MS) in the US....

Oct 27, 2010, 08:00 ET

The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market

BioTrends Research Group, Inc. released two syndicated Nephrology TreatmentTrends® publications (TreatmentTrends®: US Nephrology Q310 and...

Oct 14, 2010, 08:00 ET

Chart Trends®: Gout Report Highlights Differences Between Primary Care Physicians and Rheumatologists in the Management of Gout and Treatment Outcomes

BioTrends Research Group, Inc. is pleased to announce the recent release of a syndicated report focused on the management and treatment of gout in...

Oct 06, 2010, 10:00 ET

New Report by BioTrends Examines the Treatment of Renal Anemia in China

BioTrends Research Group, Inc. recently published its TreatmentTrends®: Renal Anemia in China report. This report is based on survey results...

Sep 28, 2010, 09:00 ET

New BioTrends Report Explores the Clinical and Business Aspects of Renal Anemia From the Perspective of Nurses and Administrators

BioTrends Research Group, Inc. recently published its TreatmentTrends®: The Role of Anemia Managers, Practice Managers and Facility...

Sep 09, 2010, 08:00 ET

Acorda's Ampyra Continues to Gain Traction and Both Breadth and Depth of Adoption are Expected to Increase Over the Next Six Months

BioTrends released the second wave of LaunchTrends®: Ampyra, a three wave syndicated report series designed to track the uptake of Acorda's...

Sep 08, 2010, 08:00 ET

Compared to Just Two Years Ago, Primary Care Physicians Report Substantial Changes in Their Knowledge and Use of the National Kidney Foundation's Chronic Kidney Disease Staging Criteria

BioTrends Research Group, Inc. recently published its Special Report: Referrals in Nephrology II. This report is based on online survey results...

Aug 31, 2010, 10:00 ET

Reaction to Extavia Promotion is Analyzed in New Report by BioTrends

BioTrends released the third wave of LaunchTrends®: Extavia (interferon beta-1b), a four wave syndicated report series designed to track the...

Aug 31, 2010, 08:00 ET

Actemra Post-Launch Success Continues to Gain Momentum with Broader Adoption Compared to Biologic Analog Launches and a Professional Marketing Campaign That Resonates with Rheumatologists

BioTrends has released the third and final wave of LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first...

Aug 26, 2010, 08:00 ET

The Availability of Generics, the Desire to Minimize the Use of Steroids and Calcineurin Inhibitors and the Entrance of New Products May Be Driving Shifts in the Management of Kidney Transplant Patients

BioTrends Research Group, Inc. recently published its TreatmentTrends®: Kidney Transplantation report. This report is based on online survey...

Aug 24, 2010, 08:00 ET

New BioTrends Report Highlights the Current Treatment Approaches and Major Drivers of Prescribing Choice for Noninfectious Uveitis

BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Noninfectious Uveitis....

Aug 24, 2010, 08:00 ET

Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market

BioTrends Research Group, Inc. recently published its TreatmentTrends®: Vascular Access report. This report is based on online survey results...

Jul 26, 2010, 08:00 ET

US Nephrologists Report Management Changes in Kidney Disease

BioTrends Research Group, Inc. recently published its TreatmentTrends®: US Nephrology Q2 2010 report. This quarterly report series is based on...

Jul 21, 2010, 08:00 ET

Cimzia Matches Simponi on Key Performance Metrics in the Treatment of RA and Actemra Uptake Continues, Despite Need for Lab Monitoring

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Rheumatoid Arthritis 2Q 2010.  This report...

Jul 15, 2010, 08:00 ET

European Nephrologists Report on Shifting Practice Patterns for Hyperphosphatemia and Renal Anemia

BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe. The reports,...

Jul 08, 2010, 09:00 ET

Ninety Percent of Surveyed Rheumatologists Intend to Prescribe Benlysta, the First Novel Drug for the Treatment of Lupus in 50+ Years, in the First Year of Launch

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Systemic Lupus Erythematosus (SLE).  This...

Jun 15, 2010, 08:00 ET

Rheumatologists Express Significant Interest in Benlysta, the First Novel Drug for the Treatment of Lupus in Decades

BioTrends is pleased to announce the upcoming publication of a new syndicated report, TreatmentTrends®: Systemic Lupus Erythematosus (SLE)....